CA
TXG icon

Cliff Asness’s 10x Genomics TXG Stock Holding History

Cliff Asness’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.7M Sell
2,026,464
-511,792
-20% -$13.4M 0.03% 700
2026
Q1 		$53.7M Sell
2,538,256
-40,795
-2% -$816K 0.02% 705
2025
Q4 		$41.9M Sell
2,579,051
-147,941
-5% -$2.23M 0.02% 718
2025
Q3 		$31.5M Sell
2,726,992
-1,410,809
-34% -$18.4M 0.02% 722
2025
Q2 		$47.9M Buy
4,137,801
+2,925,372
+241% +$26.7M 0.04% 552
2025
Q1 		$10.6M Buy
1,212,429
+695,227
+134% +$8.76M 0.01% 854
2024
Q4 		$7.43M Sell
517,202
-211,830
-29% -$3.34M 0.01% 944
2024
Q3 		$16.4M Buy
729,032
+413,852
+131% +$8.56M 0.02% 683
2024
Q2 		$6.13M Buy
315,180
+219,945
+231% +$5.76M 0.01% 941
2024
Q1 		$3.57M Buy
95,235
+46,710
+96% +$2.05M 0.01% 1137
2023
Q4 		$2.72M Buy
48,525
+37,564
+343% +$1.63M 0.01% 1207
2023
Q3 		$452K Sell
10,961
-2,850
-21% -$148K ﹤0.01% 1884
2023
Q2 		$771K Buy
+13,811
New +$748K ﹤0.01% 1661
2021
Q2 		– Sell
-27,658
Closed -$4.91M – 2301
2021
Q1 		$4.91M Sell
27,658
-27,998
-50% -$4.83M 0.01% 831
2020
Q4 		$7.88M Buy
+55,656
New +$8.08M 0.01% 670

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cliff Asness's TXG Position: Q2 2026 in Review

Cliff Asness reduced its 10x Genomics (TXG) stake by 20% in Q2 2026, selling an estimated $13.4M and leaving 2,026,464 shares worth $74.7M. The position accounts for 0.03% of the portfolio, ranked #700.

Cliff Asness first reported a position in TXG in Q4 2020 and has held it in 15 quarters since. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Cliff Asness held 2,026,464 shares of 10x Genomics worth $74.7M as of Q2 2026.
  • Cliff Asness sold 511,792 10x Genomics shares in Q2 2026, an estimated $13.4M.
  • 10x Genomics made up 0.03% of Cliff Asness's portfolio in Q2 2026, its #700 holding.
  • Cliff Asness first reported a position in 10x Genomics in Q4 2020 and has held it in 15 quarters since.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.